InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: misiu143 post# 163193

Monday, 05/03/2021 1:20:40 PM

Monday, May 03, 2021 1:20:40 PM

Post# of 233457

I will love to see to compare against study with lenzilumab for their moderately severe patients study


Lenzilumab had 54% efficacy on their whole trial. CytoDyn is keeping their the trial results of their severe patients a secret. How bad could the data be? My guess is that the severe patients had a higher mortality percentage in the leronlimab arm. But we will never know. Nader is never going to release the data.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News